Pangali Forward P/E: Cencora, Inc. (COR)

Tandha merek Cencora, Inc. (COR)

Cencora, Inc. (COR) forward P/E ratio demonstrates a dependence on generic drug costs and logistics efficiency, with the parameter stabilizing at 16.20. Margin stability is supported by broad market coverage across the US and Europe. Business development is based on dosing automation and the implementation of RFID systems for the transportation of complex medical preparations.

COR - Rasio prakiraan rega marang bathi Cencora ing rentang 21.02.2024 - 13.11.2026

Rincian metrik lan analitis perusahaan AmerisourceBergen Corporation (COR)

- rega saiki lan proyeksi nilai saham:
Kutipan saham Cencora|COR - Rata-rata rega prakiraan
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Cencora Inc|COR - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- informasi kapitalisasi buku:
Nilai Buku saben Saham Cencora|COR - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku cencora.com|COR - Total Aset Bisnis
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Cencora, Inc.|COR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Cencora, Inc.|COR - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Cencora Inc|COR - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cencora|Indikator likuiditas cepet cencora.com
- statistik bathi lan rasio pasar:
COR - Bathi pungkasan|Proyeksi bathi mangsa ngarep Cencora, Inc.|COR - Periode bali modal bisnis|Rega marang bathi mangsa ngarep AmerisourceBergen|COR - Rasio P/E diaturake wutah|Pangali EV/EBITDA Cencora Inc|COR - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Cencora|COR - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan cencora.com|COR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cencora, Inc.
- data dodolan lan asil:
COR - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Cencora|COR - Rasio kapitalisasi pasar marang pendapatan
Analisis kabeh metrik perusahaan:COR Cencora
Produk merek Cencora, Inc.

The stability of the core workforce and targeted enhancements of IT competencies in Cencora, Inc. (COR) logistics ensure the predictability of operational flows. By analyzing the company's forward P/E ratio, an investor observes the asset's market value relative to projected net income. This indicator measures the premium the market is willing to pay for future earnings. The trend of the curve allows for the identification of overvaluation risks should the cost of capital change. This determines the long-term consensus regarding the fundamental value of the business.

Pesaing langsung

Prakiraan rega marang bathi CVS (CVS Health Corporation)|MCK - Rasio prakiraan rega marang bathi|Pangali Forward P/E CAH (Cardinal Health Corp)|HSIC - Prakiraan rega marang bathi|Prestige Consumer Healthcare - Pangali Forward P/E|Rasio prakiraan rega marang bathi Wellgistics Health Inc|111.com.cn (YI) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep RDGT|UPC (Universe Pharmacy) - Pangali Forward P/E|Prakiraan rega marang bathi Biodexa Pharma (BDRX)|Rega marang bathi mangsa ngarep Hong Kong Pharma Digital (HKPD)|BIMI - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep China Jo-Jo Drugstores, Inc. CJJD|Pangali mangsa ngarep rega marang bathi WBA